|
Volumn 105, Issue 19, 2013, Pages 1423-1424
|
Use of sentinel node biopsy expands.
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ESTROGEN RECEPTOR;
TUMOR MARKER;
ADJUVANT CHEMOTHERAPY;
ADJUVANT THERAPY;
AXILLA;
BREAST NEOPLASMS;
CANCER STAGING;
CHEMISTRY;
DISEASE FREE SURVIVAL;
FEMALE;
HUMAN;
IMMUNOHISTOCHEMISTRY;
LABORATORY DIAGNOSIS;
LYMPH NODE;
LYMPH NODE DISSECTION;
LYMPH NODE METASTASIS;
MORTALITY;
NEOPLASM RECURRENCE, LOCAL;
PATHOLOGY;
PROCEDURES;
SENTINEL LYMPH NODE BIOPSY;
SURGERY;
SURVIVAL;
TRENDS;
UTILIZATION;
AXILLA;
BREAST NEOPLASMS;
CHEMOTHERAPY, ADJUVANT;
DISEASE-FREE SURVIVAL;
FALSE NEGATIVE REACTIONS;
FEMALE;
HUMANS;
IMMUNOHISTOCHEMISTRY;
LYMPH NODE EXCISION;
LYMPH NODES;
LYMPHATIC METASTASIS;
NEOADJUVANT THERAPY;
NEOPLASM RECURRENCE, LOCAL;
NEOPLASM STAGING;
RADIOTHERAPY, ADJUVANT;
RECEPTORS, ESTROGEN;
SENTINEL LYMPH NODE BIOPSY;
SURVIVAL ANALYSIS;
TUMOR MARKERS, BIOLOGICAL;
|
EID: 84891524197
PISSN: None
EISSN: 14602105
Source Type: Journal
DOI: 10.1093/jnci/djt274 Document Type: Note |
Times cited : (1)
|
References (0)
|